LENSAR, INC. Effective Income Tax Rate Reconciliation, Deduction, Dividends, Amount
LENSAR, INC. (LNSR) reported Effective Income Tax Rate Reconciliation, Deduction, Dividends, Amount of $321.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-12.
Discontinued › Expense Statement
us-gaap:IncomeTaxReconciliationDeductionsDividends · last filed 2021-03-12
- LENSAR, INC. effective income tax rate reconciliation, deduction, dividends, amount for fiscal 2019 was $321.00K.
| Period end | Effective Income Tax Rate Reconciliation, Deduction, Dividends, Amount 12 month |
|---|---|
| 2019-12-31 | $321.00K 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |